Navigation Links
Elsevier Announces Two Tetrahedron Symposia for 2012
Date:1/10/2012

AMSTERDAM, January 10, 2012 /PRNewswire/ --

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced it will organize an extra Tetrahedron Symposium in 2012. In an effort to bring the world class speakers in bioorganic and organic medicinal chemistry closer to researchers, Tetrahedron's annual symposium will this year be held in two locations, one in Europe and one in Asia.

Professor Chi-Huey Wong, Academia Sinica, Taiwan and Chairman of the 13th Tetrahedron Symposium Asia, said of the planned symposium in Taipei, "I am excited by this novel concept of having the world-class Tetrahedron Symposium hosted in two venues in 2012. This will enable many more scientists to participate than is possible for more traditional meetings. I am also very pleased that so many distinguished colleagues have enthusiastically agreed to participate."

Professor Stephen Neidle, UCL School of Pharmacy, London and Chairman of the 13th Tetrahedron Symposium Europe, said of the planned symposium in Amsterdam, "These are exciting times for the chemistry and life sciences field and I am delighted that the planned symposium will reflect this, with an outstanding group of speakers. The symposium will also be an opportunity for many scientists to present and discuss their latest work in the stimulating environment of the Tetrahedron Symposium."

Diddel Francissen, Executive Publisher of Elsevier's Tetrahedron journals added, "Nothing compares to actually physically attending a symposium. With top international speakers such as Michael Famulok (Europe), Shigeki Sasaki (Asia), Clifton Barry (USA), the symposium can be held anywhere in the world. We are very pleased to have created more opportunities for researchers across the word to attend the event, present their work and interact with internationally renowned scientists. This symposium duplication is a first for Elsevier, and if succes
'/>"/>

SOURCE Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Elsevier is Expanding eClinical Solutions in Europe
2. Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States
3. Elsevier Selects BrainTrack Directory as Supplier of College Data
4. Elsevier is Meeting Todays Medical Students Needs With Online, Mobile and Print Tools
5. InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools
6. Gold Standard/Elsevier Launches Clinical Pharmacology Mobile
7. Gold Standard/Elsevier Offers Timely, Transparent, Reliable Drug Pricing Data, Including Average Wholesale Price (AWP)
8. Elsevier/MC Strategies Partners with American Association of Critical-Care Nurses to Launch Interactive, Online Pharmacology Course
9. Elsevier Appoints Martin OMalley as Managing Director of New Global Sales Group in Science & Technology Division
10. Elsevier Appoints Top Diabetes and Endocrinology Researchers as Editors
11. Elsevier Introduces SciVerse, an Innovative Platform for Accelerating Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014 /PRNewswire-iReach/ -- The global ... of products, methods, applications, end users, and geographies. ... in the microbial identification market. This favorable growth ... (per test) and the time required for microbial ... technological advancements. Furthermore, genotypic methods have high applications ...
(Date:7/29/2014)... -- Amgen (NASDAQ: AMGN ) today announced ... results include: , Total revenues increased 11 percent ... driven by strong performance across the portfolio, particularly Enbrel ... (denosumab) and XGEVA ® (denosumab). , ... higher revenues and a significant increase in the profitability ...
(Date:7/29/2014)... 29, 2014  Express Scripts Holding Company (Nasdaq: ... attributable to Express Scripts stockholders of $515.2 million, or ... as detailed in Table 4, was $1.23 for the ... positioned to serve our clients with scale, alignment and innovative ... the health outcomes of our members," stated George Paz, chairman ...
Breaking Medicine Technology:Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 2Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 3Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 4Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 5Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 6Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 2Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 3Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 4Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 5Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 6Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 7Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 8Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 9Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 10Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 11Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 12Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 13Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 14Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 15Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 16Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 17Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 18Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 19Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 20Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 21Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 22Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 23Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 24Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 25Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 2Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 3Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 4Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 5Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 6Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 7
... 2011  TransTech Medical Solutions ( http://www.transtechmedical.com ), today announced ... for Transcription Services in the 2011 Top ... report.  TransTech has previously been ranked #3 in ... the highest overall performance score and 100% of the ...
... 2011  Today, the Consumer Healthcare Products Association (CHPA), announced Tammy ... Five Moms campaign to raise awareness of teen ... two teenage boys and a high school math teacher from ... dangers of substance abuse. Millions of Americans ...
Cached Medicine Technology:TransTech Medical Solutions Ranked #1 by KLAS for 2011 2CHPA's Five Moms Campaign to Stop Medicine Abuse Welcomes New Mom Tammy Walsh 2CHPA's Five Moms Campaign to Stop Medicine Abuse Welcomes New Mom Tammy Walsh 3
(Date:7/29/2014)... Recently, iFitDress.com, a well-known wedding dress manufacturer ... bridal gowns . Aside from this, it has announced that ... 68 percent off. All of its old and new clients ... sales representative says excitedly, “We are pleased to release the ... there are a lot of amazing items. It is true ...
(Date:7/29/2014)... City, MO (PRWEB) July 30, 2014 ... practices have recently been awarded the Patient-Centered Medical ... by the National Committee for Quality Assurance. Only ... achieved NCQA Level I, Level 2, or Level ... who participate in Patient-Centered Medical Home report faster ...
(Date:7/29/2014)... St. Petersburg, FL (PRWEB) July 30, 2014 Phytceramides ... explains how and why in her new book. , Today is ... Phytoceramides: Anti Aging At Its Best . The book is ... larger skin care book, but felt that Phytoceramides were ... sense to bring out this focused book now," says Kathy Heshelow, ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 1Heart ... senior communities with focus on Brain Fitness Education ... in Ventura. Brain Fitness Program Director Tee Barr ... Aegis Memory Care unit and the Assisted Living ... Aegis Life Enrichment Director Christy Rozsa and Aegis ...
(Date:7/29/2014)... 2014 Dignity Sciences Limited, a privately ... a Phase I trial with DS107G, an oral formulation ... was a randomized, placebo-controlled, double-blind, single-ascending and multiple dose ... and effect of food on DS107G in healthy subjects. ... of DGLA following both single and multiple oral doses ...
Breaking Medicine News(10 mins):Health News:Cheap Satin Bridal Gowns Recently Provided By Well-known Supplier iFitDress.com 2Health News:Saint Luke’s Medical Group Awarded Patient-Centered Medical Home 2011 Level 3 Recognition 2Health News:Last Day New Book Is Available at No Cost: Phytoceramides, Anti Aging At Its Best by Sublime Beauty Founder® Kathy Heshelow 2Health News:Last Day New Book Is Available at No Cost: Phytoceramides, Anti Aging At Its Best by Sublime Beauty Founder® Kathy Heshelow 3Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 2Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 3Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 4Health News:DS107G-01 – Successful Completion of Phase I Oral DGLA Clinical Trial 2
... Amilpar (Bovespa: AMIL3;,Bloomberg: AMIL3 BZ and APAR < GO >; ... results for the third quarter,of 2009. , ... thousand at the end of September 2009,2.7% up on 3Q08 and ... Operating Revenues totaled R$ 1,237.1 million in 3Q09, 8.4% up,year-on-year and ...
... 11 In its continuing initiatives around Doing What,s Right, ... as part of its involvement in the Clinton Global Initiative ... brings world leaders from a variety of backgrounds together to ... some of the world,s most pressing challenges. , SC ...
... sick, but elderly more likely to die , WEDNESDAY, Nov. 11 ... finds that while babies and people under the age of 40 ... death rates. , The research, published online Nov. 11 in ... in the Mexican Institute for Social Security network, who became sick ...
... published reports , WEDNESDAY, Nov. 11 (HealthDay News) -- ... company suggests that clinical data was manipulated to make ... than it actually was, thereby increasing possibilities for its ... means we,re not seeing the full picture, and the ...
... ... also desperate pioneers whose drug use had gotten the better of them every ... whether an epilepsy drug could reduce their use of cocaine. In the end, ... the final three weeks of the study with no signs of cocaine use ...
... 11 An article running in the new issue ... , "Silent Epidemic of Viral Hepatitis May Lead to ... for Congress to act on new bipartisan legislation, HR ... research, and medical management referral program for chronic hepatitis ...
Cached Medicine News:Health News:Amilpar - Revenues Grow 8% and Net Income Improves 28% in 3Q09 2Health News:SC Johnson Makes Commitment to Clinton Global Initiative 2Health News:SC Johnson Makes Commitment to Clinton Global Initiative 3Health News:Older People at Greater Risk of Swine Flu Death 2Health News:Trial Data on Anti-Seizure Drug Might Have Been Manipulated: Report 2Health News:Trial Data on Anti-Seizure Drug Might Have Been Manipulated: Report 3Health News:Anti-Epileptic Drug Curbs Cocaine Use in First Study Comparing Placebo Dose 2Health News:Anti-Epileptic Drug Curbs Cocaine Use in First Study Comparing Placebo Dose 3Health News:Anti-Epileptic Drug Curbs Cocaine Use in First Study Comparing Placebo Dose 4Health News:NVHR: New JAMA Article Underscores Urgent Need for Congress to Act on Viral Hepatitis Detection, Management Funding 2
...
...
...
A modular concept consisting of two J-Arms, to be fixed at any position of the skull clamp, allowing to the surgeon an unobstructed access to the surgical field....
Medicine Products: